Altogether, these studies suggest that the blocking of the SHH-GLI signaling pathway will provide an attractive therapeutic strategy to treat advanced and metastatic PC caused by the prostate stem/progenitor cells and prevent disease relapse. This evidence concerns the gene SHH and pachyonychia congenita.